Orphan drug boom comes with a steady stream of outsourcing

With the FDA approving a record number of orphan drugs in 2014, sponsors weren’t the only ones to reap profits from their development. https://www.outsourcing-pharma.com/Clinical-Development/Orphan-drug-boom-comes-with-a-steady-stream-of-outsourcing

ISR Projects a 7.4% Compound Annual Growth Rate for the CRO Market through 2019

Informing the drug development and commercialization industry Cary, N.C. – February 11, 2015 – Industry Standard Research (ISR Reports) has announced the availability of a new report titled “2015 Edition of the CRO Market Size Projections: 2012-2019.” For this report, ISR has utilized both publically available information and data obtained through its syndicated primary market … Continued

Triangle CROs adopt innovative methods to recruit clinical trial patients

Companies that help pharmaceutical and biotechnology companies conduct clinical trials are increasingly focused on unclogging what can be a major bottleneck – recruiting sufficient numbers of patients willing to test an experimental drug in a reasonable period of time. The stakes are high for these contract research organizations, or CROs – an industry that is … Continued

ISR CUSTOMERS